Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia. Issue 8 (August 2013) - Al-Riyami, Arwa Z.; Hudoba, Monika; Young, Sean; Forrest, Donna